BVS vs ETR · rev $573.3M vs P/E 28, rev $12.95B
Bioventus Inc (BVS) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
BVS currently screens at market cap $495.1M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the BVS and ETR stock pages for the full models.
Not investment advice.